Cells for Cells S.A.

Our mission is to advance innovative solutions to unresolved chronic diseases and address the growing challenges of the biomedical industry through the promotion of translational research along with the development and commercialization of biotechnology platforms. We develop life-changing therapies and implants for unresolved chronic diseases and tackle the growing challenges of the biomedical industry through visionary life science tools. We aspire to become a world-renowned catalyst of regenerative medicine companies and products that contribute to enabling access to advanced medical treatments with high impact on patients’ health and well-being. Cells for Cells is strongly committed to time-sensitive and cost-efficient clinical and IP validation, a pledge that allowed us to achieve the first-ever clinical proof of principle of an exosome-produced therapy for joint disease. We aim to provide hope to patients in urgent need of satisfactory medical solutions by reducing cost and geographical barriers to accessing advanced therapeutic products. At Cells for Cells, we are devoted to quality. Since 2010, we have been Latin America’s leading company producing cell therapies and innovative tissue engineering solutions, each complying with national and international Good Manufacturing Practices (GMP) regulations related to quality and safety. We focus on continuous improvement thanks to our Quality Management System (QMS) based on ISO 9001:2015, our corporate values, and the experience and professionalism of our teams.